MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Case-control study of risk developing parkinsonism in Alzheimer’s disease in relation to hypertension, dyslipidemia, and diabetes in Taiwan

W. Lin, PY. Chiu (Changhua, Taiwan)

Meeting: 2019 International Congress

Abstract Number: 958

Keywords: Dementia, Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To clarify the relationship between vascular risk factors and parkinsonism in Alzheimer’s disease

Background: This case-control study investigated the associations of a history of hypertension, dyslipidemia, and diabetes mellitus with the risk of parkinsonism in Alzheimer’s disease with dementia in Taiwan.

Method: A total of 1,243 Alzheimer’s disease patients were included in the study. Included were 250 cases, onset within 20 years of parkinsonism. Controls were 993 inpatients and outpatients with Alzheimer’s disease. All Alzheimer’s disease cases were diagnosed according to revised NIA-AA criteria. Data on the vascular risk factors and confounders were obtained from a self-administered questionnaire. The vascular risk factors were defined based on drug treatment and International Classification of Diseases (ICD) code.

Results: The proportions of hypertension, dyslipidemia, and diabetes mellitus prior to the onset of parkinsonism were 21.2%, 43.6%, and 24.8%, respectively. Hypertension, dyslipidemia, and diabetes mellitus were significantly associated with an increased risk of parkinsonism: the adjusted ORs were 2.335 (95% CI: 1.75–3.115), 2.054 (95% CI: 1.433–2.945), and 1.913 (95% CI: 1.367–2.678), respectively.

Conclusion: We found evidence of significant associations of hypertension, dyslipidemia, and diabetes mellitus with the risk of parkinsonism in Alzheimer’s disease in Taiwan. Further well-designed investigations of the association of vascular risk factors with the risk of parkinsonism in Alzheimer’s disease are needed.

To cite this abstract in AMA style:

W. Lin, PY. Chiu. Case-control study of risk developing parkinsonism in Alzheimer’s disease in relation to hypertension, dyslipidemia, and diabetes in Taiwan [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/case-control-study-of-risk-developing-parkinsonism-in-alzheimers-disease-in-relation-to-hypertension-dyslipidemia-and-diabetes-in-taiwan/. Accessed July 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/case-control-study-of-risk-developing-parkinsonism-in-alzheimers-disease-in-relation-to-hypertension-dyslipidemia-and-diabetes-in-taiwan/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • #24970 (not found)
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley